Latest Content

FDA Approves Bosaya and Aukelso Biosimilars for Solid Tumor Care

September 18th 2025, 3:00pm

By Ryan Scott

Article

The FDA approved Bosaya and Aukelso, biosimilars of Prolia and Xgeva, respectively, for the treatment of solid tumors, like breast and prostate cancer.

How to Access Support Resources for Rare Cancers

September 18th 2025, 1:00pm

By Dr. Rosario Ligresti

Video

Being diagnosed with a rare cancer like GIST can be overwhelming, highlighting the need for support networks, says Dr. Rosario Ligresti.

The Defining Moments of Support After Hearing ‘You Have Cancer’

September 17th 2025, 9:00pm

By Linda Cohen

Article

I reflect on how my family and friends showed love in different ways during the early days of my chronic cancer diagnosis.

Off-the-Shelf Immunotherapy May Offer Benefits in Kidney Cancer

September 17th 2025, 8:00pm

By Ryan Scott

Article

Researchers have created a novel immunotherapy for metastatic kidney cancer that could provide a new treatment option for patients with limited options.

Gleevec Associated With Long-Term Effectiveness in Treating GIST

September 17th 2025, 7:00pm

By Alex Biese

Article

For patients with advanced GIST, complete surgical removal of metastases and full response to Gleevec are associated with roughly double the survival time.

The Days of a Breast Cancer Survivor

September 17th 2025, 5:00pm

By Laura Yeager

Article

Having been through two bouts of breast cancer, I am happy to be on this planet with my family, friends and neighbors.

Prostate Cancer Survivor Encourages Men to Speak Up and Get Tested

September 17th 2025, 4:00pm

By Ryan Scott

Article

Bob Lane, a prostate cancer survivor, discusses the stigma men often feel when talking about prostate cancer.

Ligufalimab Gains FDA Orphan Drug Status for Acute Myeloid Leukemia

September 17th 2025, 3:10pm

By Spencer Feldman

Article

The FDA granted orphan drug designation to ligufalimab for AML, reflecting its potential as an immune-based therapy that may offer new options for patients.

Expert Highlights Importance of Understanding Myelofibrosis Treatments

September 17th 2025, 1:00pm

By Dr. Prithviraj Bose

Video

Dr. Prithviraj Bose discusses how patients with myelofibrosis can better understand their options and access the most up-to-date advancements in care.

What the Changing Seasons Taught Me About Cancer and Life

September 16th 2025, 9:00pm

By Tamron Little

Article

The first day of fall comes on September 22, and every year it feels like a reminder to pause.

Understanding the Importance of Biomarker Testing in Lung Cancer

September 16th 2025, 8:00pm

By Dr. Joshua K. Sabari

Video

Dr. Joshua K. Sabari sat down with Terri Conneran at the 2025 World Conference on Lung Cancer for a conversation on the importance of biomarker testing.

How to Individually Tailor Myelofibrosis Treatment Options

September 16th 2025, 7:00pm

By Ryan Scott

Article

Dr. Prithviraj Bose explains how doctors tailor myelofibrosis treatments and how patients can work with their care teams to navigate options.

A Day in the Life of a Breast Cancer Survivor

September 16th 2025, 5:00pm

By Bonnie Annis

Article

Since being diagnosed with breast cancer, my life has drastically changed. Time has helped each day become more precious and has caused me to become more grateful.

Jakafi for Myelofibrosis Associated With Skin Cancer, Shingles Risk

September 16th 2025, 4:00pm

By Alex Biese

Article

For patients with myelofibrosis, there is a risk of non-melanoma skin cancer or shingles among patients who received long-term treatment with Jakafi.

FDA Grants Designation to Investigational Drug for Head and Neck Cancer

September 16th 2025, 3:00pm

By Ryan Scott

Article

The FDA has granted fast track designation to the investigational drug CRB-701 for recurrent or metastatic head and neck squamous cell carcinoma.